“…Equally worrisome are reports of gender-related psychological and behavioral attributes of young female patients with CF that could place them at a disadvantage compared with their male peers. These include increased difficulty in coping with the disease, increased illness-related strains and worries, greater depression, decreased quality of life scores, greater treatment discouragement, and greater acceptance of being underweight (45)(46)(47)(48)(49)(50)(51)(52), which may contribute to decreased treatment adherence and worse outcomes (45-47, 49, 64-66). The phenomenon of decreased survival in females appears to be confined to patients of age 1-20 years (30,33,76).…”